Details

Autor(en) / Beteiligte

• Rochette, C
• Castinetti, F
• Brue, T

Titel

Acromegaly and Cushing's disease: Persistence of comorbidities after the control of hypersecretion

Ist Teil von

• Annales d'endocrinologie, 2016-10, Vol.77 Suppl 1, p.S19

Ort / Verlag

France

Erscheinungsjahr

2016

Quelle

MEDLINE

Beschreibungen/Notizen

• Acromegaly and Cushing's disease lead to common and distinct comorbidities. Currently available treatments lead to the control of hyper secretion in the majority of cases. However, the prevalence of the comorbidities does not always go back to the one of the normal population after remission. For instance, about 1/3 of acromegalic patients with diabetes and half of patients with Cushing's disease and diabetes will have normal blood glucose values after remission. In contrast, high blood pressure frequently recovers after remission in both diseases. In contrast, while patients with acromegaly improve their lipid profile, patients with Cushing's disease frequently remain hypertriglyceridemic. Many other comorbidities (cardiovascular disease, bone alterations, altered quality of life) may persist after the control of hyper secretion. The aim of this review is to focus on the outcome of patients with acromegaly and Cuhing's disease, and to suggest the optimal follow-up of such patients in a multidisciplinary approach. These points have been discussed during the 2016 European Congress of Endocrinology, notably by J.Romijn and E.Valassi.